Login

Wanbury Ltd.

₹249.45

Overview Charts Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Corp. Action Documents
Consolidated
Standalone

Wanbury Ltd.

  • NSE : WANBURY
Add Alert
Add Watchlist

₹249.45

₹249.45

-5.05 (-1.98%) - 2 Oct 2025 04:26 PM
  • NSE : WANBURY

About Company

Wanbury Limited, one of India’s fastest growing pharmaceutical companies amongst the ‘Top 50 Companies’ in India (as per ORG-IMS), has a strong presence in API global market and domestic branded Formulation. Wanbury’s major trust area lies in Active Pharmaceutical Ingredient (API) Sales & Marketing in several countries and Pan-India Formulation presence.

Market Cap. ₹ 870 Cr.
52 Week - High/Low ₹ 330/154
P/E Ratio 19.04
P/B Ratio 14.68
Enterprise Value ₹ 1,030 Cr.
ROE % 84.21
RSI Value 40.24
EMA 50 263.01
EMA 200 253.19
Market Cap. ₹ 870 Cr.
52 Week - High/Low ₹ 330/154
P/E Ratio 19.04
P/B Ratio 31.14
Enterprise Value ₹ 1,046 Cr.
ROE % N/A
RSI Value 40.24
EMA 50 263.01
EMA 200 253.19
Add Parameters

Growth

Chart Icon
View Full Chart

Valuation

Calculators

Peer Comparison

Industry - Pharmaceuticals & Drugs

* Please refer to the Standalone data if Consolidated financial data for the company is not available.

Shareholding Pattern Numbers in percentages

Insight market
Terms | Privacy | Contact Us
Copyright © 2025 All rights reserved with INVESMATE INSIGHTS PRIVATE LIMITED | All logos and Trademarks registered with their respective owners.